TABLE 2.
Azithromycin negatively impacts diagnostic positivity (phage excluded)
| Dxg | Na | Dx positive [% (no. positive/total no.)] by phage exposure: |
ORb | OR_MLEc | CIc | P valued | |
|---|---|---|---|---|---|---|---|
| Exposed | Unexposed | ||||||
| RDT | 63 | 0 (0/18) | 49 (22/45) | 0.000 | 0.000 | 0.000–0.282 | <0.001 |
| qPCR | 63 | 33 (6/18) | 82 (37/45) | 0.108 | 0.113 | 0.026–0.437 | <0.001 |
| Microscopye | 58 | 44 (7/16) | 60 (25/42) | 0.529 | 0.535 | 0.139–1.973 | 0.378 |
| Culturef | 27 | 0 (0/5) | 59 (13/22) | 0.000 | 0.000 | 0.000–0.997 | 0.041 |
Number of V. cholerae-positive samples by nl-qPCR without lytic bacteriophage (ICP1, ICP2, and ICP3) detected in the stool by PCR.
OR, sample odds ratio.
Estimated odds ratio with conditional maximum likelihood estimate (MLE); CI, 95% confidence interval.
Fisher's exact test.
Indeterminant samples were considered negative; limit of detection 100 to 1,000 CFU/ml.
Insufficient samples with phage for statistical analysis.
Dx, diagnostic.